Aptamers are short, single-stranded oligonucleotides that bind to their targets with high
affinity and specificity. Usually, aptamers are selected experimentally using SELEX …

Nucleic acid aptamers hold great promise for therapeutic applications due to their favorable
intrinsic properties, as well as high-throughput experimental selection techniques. Despite …

The lack of a specific targeting strategy against cancer stem cells in current cancer treatment
regimens is at least partly responsible for life‐threatening cytotoxicity for patients undergoing …

Aptamers are molecules that reveal highly complex and refined molecular recognition
properties. These molecules are capable of binding with high affinity and selectivity to …

An aptamer is a single-stranded DNA or RNA that binds to a specific target with high binding
affinity. Aptamers are developed through the process of systematic evolution of ligands by …

Aptamers, the nucleic acid analogs of antibodies, bind to their target molecules with
remarkable specificity and sensitivity, making them promising diagnostic and therapeutic …

RNA aptamers are single-stranded nucleic acids of 20–100 nucleotides, with high sensitivity
and specificity against particular molecular targets. In vitro production and selection of …

Aptamers are short, single-stranded DNA or RNA oligonucleotide molecules that function as
synthetic analogs of antibodies and bind to a target molecule with high specificity. Aptamer …

DNA aptamers against carcinoembryonic antigen (CEA) have been identified through the
systematic evolution of ligands by exponential enrichment (SELEX) technique, but their …

Aptamers are short, single‐stranded nucleic acid (DNA or RNA) oligonucleotides that can be
obtained by a technique called systematic evolution of ligands by exponential enrichment …